Axon Q3 Miss and Guidance Cut Trigger Margin-of-Safety Reassessment

What happened

Axon's Q3 2026 results missed expectations and management lowered its full-year 2026 outlook, citing rising costs. This development directly validates the margin and cost concerns previously flagged in the DeepValue analysis, where tariff-driven gross margin pressure and elevated stock-based compensation were key risks. While demand for TASER devices and software subscriptions remains robust, the inability to convert that demand into expected profitability has damaged near-term credibility. The stock had been trading at a rich valuation (P/E ~319x, EV/EBITDA ~207x at the time of the last report), leaving little room for execution missteps. The miss and guidance cut likely pushed the stock toward or below the previously identified attractive entry of $440, but the deterioration in operating leverage reduces the margin of safety even at lower prices.

Implication

The Q3 miss suggests that the base case of 27–30% revenue growth with ~25.5% adjusted EBITDA margin is now at risk, and the bear case of <115% NRR and lower growth gains probability. The previously computed scenario probabilities should be updated: bear case (implied value $380) likely rises from 25% to at least 35–40%, while base case ($520) falls to around 40–45% and bull case ($650) drops to 15–20%. The deterioration in profitability and guidance cut weakens the investment thesis until management can demonstrate that tariffs and SBC are being absorbed without further margin compression; the next 2–3 quarters are critical. If NRR falls below 115% or adjusted gross margin declines again in Q4, the stock could re-rate toward the bear case value of $380, representing significant further downside from current levels. Conversely, if the company re-accelerates bookings and shows cost control, the stock could recover, but given the elevated multiple and execution uncertainty, a wait-and-see approach with strict monitoring is warranted.

Thesis delta

The Q3 miss and guidance cut shift the thesis from 'wait for confirmation' to 'confirmation of margin deterioration has arrived'. The probability-weighted fair value estimate moves down toward the bear case of $380, as the base case of $520 relies on margin stability that has not materialized. A re-entry is not justified until there is at least one quarter of stable or improving adjusted gross margin and NRR holding above 115%.